Home › Trial NCT00006267
Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
- Trial IDNCT00006267
- StatusWithdrawn
- PhasePhase 2
- Study typeInterventional
- SponsorGynecologic Oncology Group
- Enrollment—
- Start date—
- ConditionsOvarian Cancer · Primary Peritoneal Cavity Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.